Invention Grant
![4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors](/docs/US/2018-08-07/US10040803B2/abs.jpg.600x600.jpg)
- Patent Title: 4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors
-
Application No.: US15821962Application Date: 2017-11-24
-
Publication No.: US10040803B2Publication Date: 2018-08-07
- Inventor: Tae Bo Sim , Ho Jong Yoon , In Jae Shin , Yun Ju Nam , Hwan Geun Choi
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seoul
- Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Seoul
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: KR10-2016-0158186 20161125
- Main IPC: C07D495/02
- IPC: C07D495/02 ; C07D495/04 ; A61P35/00
![4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors](/abs-image/US/2018/08/07/US10040803B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a novel 4-((2-acrylamidophenyl)amino)thieno[3,2-d]pyrimidine-7-carboxamide compound, an anticancer agent containing the compound as an active ingredient and an intermediate compound for preparing the compound.
Public/Granted literature
Information query
